Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Volavka

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Frontiers in Psychology|November 8, 2021
Willingness to Vaccinate Against COVID-19: The Role of Health Locus of Control and Conspiracy TheoriesVojtech Pisl, Jan Volavka, Edita Chvojkova, et al.
The Journal of Clinical Psychiatry|May 4, 2006
Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study dataLeslie Citrome, Jan Volavka, Pal Czobor, et al.
Neuropsychiatric Disease and Treatment|June 27, 2009
Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidoneHong Liu-Seifert, Bruce J Kinon, Christopher J Tennant, et al.
Archives of General Psychiatry|May 14, 2003
Placebo or active control trials of antipsychotic drugs?W Wolfgang Fleischhacker, Pal Czobor, Martina Hummer, et al.
The Journal of the American Academy of Psychiatry and the Law|June 30, 2005
A cognitive, behaviorally based program for patients with persistent mental illness and a history of aggression, crime, or both: structure and correlates of completers of the programKathy Yates, Michal Kunz, Pal Czobor, et al.
Psychiatric Services (Washington, D.C.)|June 4, 2004
Course of patients with histories of aggression and crime after discharge from a cognitive-behavioral programMichael Kunz, Kathy F Yates, Pal Czobor, et al.
Biological Psychiatry|June 25, 2002
Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary studyMatthew J Hoptman, Jan Volavka, Glyn Johnson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 26, 2015
Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studiesPál Czobor, Richard A Van Dorn, Leslie Citrome, et al.
BMJ (Clinical Research Ed.)|July 11, 2006
Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up studyJari Tiihonen, Kristian Wahlbeck, Jouko Lönnqvist, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 14, 2008
A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophreniaJeffrey A Lieberman, Kelly Papadakis, John Csernansky, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Frontiers in Psychology|November 8, 2021
Willingness to Vaccinate Against COVID-19: The Role of Health Locus of Control and Conspiracy TheoriesVojtech Pisl, Jan Volavka, Edita Chvojkova, et al.
The Journal of Clinical Psychiatry|May 4, 2006
Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study dataLeslie Citrome, Jan Volavka, Pal Czobor, et al.
Neuropsychiatric Disease and Treatment|June 27, 2009
Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidoneHong Liu-Seifert, Bruce J Kinon, Christopher J Tennant, et al.
Archives of General Psychiatry|May 14, 2003
Placebo or active control trials of antipsychotic drugs?W Wolfgang Fleischhacker, Pal Czobor, Martina Hummer, et al.
The Journal of the American Academy of Psychiatry and the Law|June 30, 2005
A cognitive, behaviorally based program for patients with persistent mental illness and a history of aggression, crime, or both: structure and correlates of completers of the programKathy Yates, Michal Kunz, Pal Czobor, et al.
Psychiatric Services (Washington, D.C.)|June 4, 2004
Course of patients with histories of aggression and crime after discharge from a cognitive-behavioral programMichael Kunz, Kathy F Yates, Pal Czobor, et al.
Biological Psychiatry|June 25, 2002
Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary studyMatthew J Hoptman, Jan Volavka, Glyn Johnson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 26, 2015
Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studiesPál Czobor, Richard A Van Dorn, Leslie Citrome, et al.
BMJ (Clinical Research Ed.)|July 11, 2006
Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up studyJari Tiihonen, Kristian Wahlbeck, Jouko Lönnqvist, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 14, 2008
A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophreniaJeffrey A Lieberman, Kelly Papadakis, John Csernansky, et al.
Pageof 10